Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Pennant Group
PNTG
$1.37B
| $1.78M | ﹤0.01% |
48,191
-17,995
| -27% | -$588K |
|
2027
Princeton Bancorp
BPRN
$292M
| $1.78M | ﹤0.01% |
46,786
+9,763
| +26% | +$349K |
|
2028
Neuropace
NPCE
$507M
| $1.77M | ﹤0.01% |
111,699
-62,612
| -36% | -$1.01M |
|
2029
Monro
MNRO
$391M
| $1.77M | ﹤0.01% |
+103,679
| New | +$1.7M |
|
2030
Franklin Covey
FC
$212M
| $1.77M | ﹤0.01% |
72,303
-14,000
| -16% | -$319K |
|
2031
Direxion Daily TSLA Bear 1X ETF
TSLS
$58.9M
| $1.77M | ﹤0.01% |
+34,600
| New | +$1.93M |
|
|
LINE
2032
Lineage Inc
LINE
$8.63B
| $1.77M | ﹤0.01% |
40,900
-251,800
| -86% | -$9.9M |
|
|
ALH
2033
Alliance Laundry Holdings
ALH
$4.42B
| $1.77M | ﹤0.01% |
66,700
-140,600
| -68% | -$3.51M |
|
2034
Schwab 1000 Index ETF
SCHK
$5.85B
| $1.77M | ﹤0.01% |
+49,000
| New | +$1.71M |
|
2035
Upbound Group
UPBD
$1.08B
| $1.77M | ﹤0.01% |
83,200
+19,300
| +30% | +$361K |
|
2036
Lineage Cell Therapeutics
LCTX
$276M
| $1.76M | ﹤0.01% |
1,344,829
-780,271
| -37% | -$1.08M |
|
2037
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.92B
| $1.76M | ﹤0.01% |
44,609
+30,809
| +223% | +$1.22M |
|
2038
Loar Holdings
LOAR
$6.34B
| $1.76M | ﹤0.01% |
21,800
-33,300
| -60% | -$2.12M |
|
2039
Greene County Bancorp
GCBC
$590M
| $1.75M | ﹤0.01% |
52,200
+1,200
| +2% | +$30.9K |
|
2040
Advantage Solutions
ADV
$396M
| $1.75M | ﹤0.01% |
40,531
+7,056
| +21% | +$250K |
|
2041
Driven Brands
DRVN
$2.18B
| $1.74M | ﹤0.01% |
+125,100
| New | +$1.65M |
|
2042
World Kinect Corp
WKC
$1.81B
| $1.74M | ﹤0.01% |
52,886
+6,400
| +14% | +$178K |
|
2043
Aspen Aerogels
ASPN
$407M
| $1.74M | ﹤0.01% |
+274,392
| New | +$1.35M |
|
2044
Vanguard Dividend Appreciation ETF
VIG
$112B
| $1.74M | ﹤0.01% |
7,352
-2,348
| -24% | -$539K |
|
2045
Farmers & Merchants Bancorp
FMAO
$480M
| $1.74M | ﹤0.01% |
+56,881
| New | +$1.57M |
|
2046
Tucows
TCX
$120M
| $1.74M | ﹤0.01% |
128,951
-6,900
| -5% | -$105K |
|
2047
Voyager Therapeutics
VYGR
$210M
| $1.73M | ﹤0.01% |
495,236
-82,788
| -14% | -$314K |
|
2048
Aquestive Therapeutics
AQST
$654M
| $1.73M | ﹤0.01% |
+416,248
| New | +$1.75M |
|
2049
Chord Energy
CHRD
$8.07B
| $1.73M | ﹤0.01% |
15,094
-93,058
| -86% | -$12.6M |
|
2050
ImmuCell
ICCC
$89.4M
| $1.72M | ﹤0.01% |
171,089
+19,300
| +13% | +$170K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.